VITAL CAPACITY AS A PREDICTOR OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY
VITAL CAPACITY AS A PREDICTOR OF CARDIOVASCULAR-DISEASE - THE FRAMINGHAM-STUDY
复制标题
DOI：
10.1016/0002-8703(83)90532-x
复制
发表时间：
1983-01-01
影响因子：
4.8
通讯作者：
LEW, EA
中科院分区：
文献类型：
--
作者：
KANNEL, WB;HUBERT, H;LEW, EA
用力肺活量（FVC）是一项成熟的、古老的试验，主要用于评估肺功能的某些方面。然而，其在评价心血管疾病发病率和死亡率方面的效用仍然存在争议1。2-4 Levine5建议将该测试作为评估心力衰竭进展的有用的办公室程序。最近的前瞻性研究“Frachial Study”也证明了它在预测心力衰竭方面的效用。现在有了20年的随访数据，可以检查FVC与每种主要心血管疾病的发生和心血管死亡率的关系。本报告的目的是这样做，考虑到主要的心血管危险因素，胸部畸形，肺部疾病和心力衰竭。
The forced vital capacity (FVC) is an established, venerable test used principally to assess certain aspects of pulmonary function.* However, its utility in the evaluation of cardiovascular disease incidence and mortality has remained controversia1. 2-4 Levine5 proposed the test as a useful office procedure for evaluating the progress of cardiac failure. More recent prospective investigation@ in the Framingham Study have demonstrated its utility for pre-dicting cardiac failure as well. Now that 20 years of follow-up data are available, it is possible to examine the relationship of the FVC to development of each of the major cardiovascular diseases and to cardiovascular mortality. The purpose of this report is to do so, taking into account the major cardiovascular risk factors, chest deformity, pulmonary disease, and cardiac failure.